Pharming Group N.V. - Ordinary Shares / American Depositary Shares (PHAR)

CUSIP: 71716E105

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Ordinary Shares / American Depositary Shares
Shares outstanding
705,983,417
Total 13F shares
140,452
Share change
+67,938
Total reported value
$2,481,786
Price per share
$17.67
Number of holders
10
Value change
+$1,200,542
Number of buys
5
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 71716E105?
CUSIP 71716E105 identifies PHAR - Pharming Group N.V. - Ordinary Shares / American Depositary Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Pharming Group N.V. - Ordinary Shares / American Depositary Shares (PHAR) as of Q4 2025

As of 31 Dec 2025, Pharming Group N.V. - Ordinary Shares / American Depositary Shares (PHAR) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 140,452 shares. The largest 10 holders included Silverberg Bernstein Capital Management LLC, NewEdge Advisors, LLC, MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, SmartHarvest Portfolios, LLC, MORGAN STANLEY, EverSource Wealth Advisors, LLC, Nalls Sherbakoff Group, LLC, BNP PARIBAS FINANCIAL MARKETS, and UBS Group AG. This page lists 10 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.